49
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1349679
Our passion, in all we do, is to improve the quality of individual health care through the development of gene therapy technologies.
About the Company
Rimedion, Inc is a viral vector technology company founded in 2008 by Dr. Ken Cornetta of the Indiana University Vector Production Facility (IUVPF). The Indiana University School of medicine helped to found the company to absorb and manage commercial activity of the IUPVF. By taking over the commercial activity of IUVPF, Rimedion was able to make
certification testing available and to provide production of clinical grade vectors for biotechnology companies and academic institutions. Rimedion has an exclusive license with the IUVPF to manage all outside requests thus utilizing IUVPF’s scientific expertise while providing its customers with the ability to accelerate their production development path.
